If built up successfully, the recently launched Fraunhofer Project Center for Biopharmaceutical Research in South Korea can move towards becoming a Fraunhofer Center, integrated within a Fraunhofer subsidiary – Fraunhofer Korea Research. The Fraunhofer Senate passed a resolution to negotiate the establishment of a Fraunhofer subsidiary with the Korean funding bodies.
South Korea is one of the most dynamic and economically stable countries in Asia, enjoying economic growth of over 6 percent. It is an important trading partner for Europe, with Germany’s exports to South Korea worth 14.3 billion dollars. A free-trade agreement between the EU and South Korea – the first of its kind with an Asian country – has been in place since July 2011.
Germany does not only export to South Korea, it is also one of the biggest investors in the country. German pharmaceutical and chemical companies have been a prominent fixture in South Korea for quite some time, and it is this industry’s interest in South Korea that makes it attractive to the Fraunhofer-Gesellschaft. In order to be able to offer competent advice and research services, it is not only essential for Fraunhofer to collaborate with the best international research groups. As an applied research organization it follows its export oriented clients and must also familiarize itself with markets’ cultural characteristics and specific requirements.
This international commitment is paying off. During the 2011 fiscal year, Fraunhofer’s revenues from international partners and the European Union totaled 200 million euros – excluding license fees – representing growth of 14 percent over 2010. In Asia, revenues rose by 5.3 percent to 18 million euros. This rise reflects above all strong business relationships with Japan, China and South Korea.
The region is not only interesting from an economic point of view. Asian countries are investing more and more in education and research, and their potential for innovation is rising rapidly. Those not wanting to miss out on this progression need to have a local presence and be seeking dialog and active collaboration.International experience as a recipe for success
In South Korea, the Fraunhofer Project Center for Biopharmaceutical Research was recently launched in the South Jeollanamdo province. This Project Center is being set up by the Fraunhofer Institute for Molecular Biology and Applied Ecology IME. It is financed by the Korean Ministry of Education, Science and Technology (MEST), which has identified biotechnology as one of the most important growth markets of the 21st century.
Dr. Raoul Klingner | Fraunhofer Research News
Starting school boosts development
11.05.2017 | Max-Planck-Institut für Bildungsforschung
New Master’s programme: University of Kaiserslautern educates experts in quantum technology
15.03.2017 | Technische Universität Kaiserslautern
19.07.2017 | Event News
12.07.2017 | Event News
12.07.2017 | Event News
20.07.2017 | Information Technology
20.07.2017 | Materials Sciences
20.07.2017 | Physics and Astronomy